Rockefeller Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
ACA
VPM
VCM
Rockefeller Capital Management's UTHR Position: Q1 2026 in Review
Rockefeller Capital Management increased its United Therapeutics (UTHR) stake by 18% in Q1 2026, buying an estimated $119K and bringing the position to 1,562 shares worth $926K. The position accounts for ﹤0.01% of the portfolio, ranked #1645.
Rockefeller Capital Management first reported a position in UTHR in Q1 2019 and has held it in 19 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- Rockefeller Capital Management held 1,562 shares of United Therapeutics worth $926K as of Q1 2026.
- Rockefeller Capital Management bought 239 United Therapeutics shares in Q1 2026, an estimated $119K.
- United Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #1645 holding.
- Rockefeller Capital Management first reported a position in United Therapeutics in Q1 2019 and has held it in 19 quarters since.
- 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.